Join to View Full Profile
6445 Main St# OPC24Houston, TX 77030
Phone+1 713-441-9948
Fax+1 713-790-6470
Dr. Randhawa is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of Texas M.D. Anderson Cancer CenterFellowship, Leukemia, 2014 - 2015
Medical College of Wisconsin Affiliated HospitalsFellowship, Hematology and Medical Oncology, 2011 - 2014- Medical College of Wisconsin Affiliated HospitalsResidency, Internal Medicine, 2008 - 2010
Dayanand Medical College Class of 2005
Certifications & Licensure
WI State Medical License 2009 - 2027
TX State Medical License 2017 - 2024
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2016-2017
- CMS Meaningful Use Stage 1 Certification EpicCare Inpatient 2014 Certified EHR Suite (with Beaker), Epic Systems Corporation, 2016-2017
- CMS Meaningful Use Stage 1 Certification OpTime Surgical 2014 Certified Module, Epic Systems Corporation, 2016-2017
Publications & Presentations
PubMed
- 60 citationsOral decitabine-cedazuridine versus intravenous decitabine for myelodysplastic syndromes and chronic myelomonocytic leukaemia (ASCERTAIN): a registrational, randomised...Guillermo Garcia-Manero, James McCloskey, Elizabeth A Griffiths, Karen W L Yee, Amer M Zeidan
The Lancet. Haematology. 2024-01-01 - 5 citationsUse of ifosfamide, carboplatin and etoposide in combination with brentuximab vedotin or romidepsin based on CD30 positivity in relapsed/refractory peripheral T-cell ly...Cesar Gentille, Humaira Sarfraz, Jitesh Joshi, Jasleen Randhawa, Shilpan Shah
Cancer Reports. 2022-07-01 - 49 citationsClinical effects of administering leukemia-specific donor T cells to patients with AML/MDS after allogeneic transplant.Premal Lulla, Swati Naik, Spyridoula Vasileiou, Ifigeneia Tzannou, Ayumi Watanabe
Blood. 2021-05-13
Journal Articles
- Final Outcomes of Escalated Melphalan 280 mg/m2 with Amifostine Cytoprotection Followed Autologous Hematopoietic Stem Cell Transplantation for Multiple Myeloma: High C...Neal Flomenberg, Dianna S Howard, Barry R Meisenberg, Parameswaran Hari, Gordon L Phillips, David H Vesole, Jasleen Randhawa, Aaron P Rapoport, Nature
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
